Shaanxi Xinghua Chemistry Co.,Ltd (SHE:002109)
China · Delayed Price · Currency is CNY 4.150
-0.100 (-2.35%)
At close: Feb 13, 2026
SHE:002109 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Operating Revenue | 3,627 | 4,128 | 3,611 | 3,169 | 2,721 | 1,839 |
Other Revenue | 3.52 | 3.52 | 81.22 | 88.69 | 115.78 | 100.5 |
| 3,630 | 4,131 | 3,692 | 3,258 | 2,837 | 1,940 | |
Revenue Growth (YoY) | -1.98% | 11.89% | 13.33% | 14.82% | 46.25% | -1.75% |
Cost of Revenue | 3,888 | 4,137 | 3,873 | 2,688 | 2,087 | 1,580 |
Gross Profit | -258.2 | -5.89 | -180.46 | 570.2 | 750.19 | 360.18 |
Selling, General & Admin | 190.97 | 176.07 | 163.68 | 110.39 | 88.01 | 82.73 |
Other Operating Expenses | 61.95 | 36.76 | 29.87 | 27.32 | 25.47 | 17.97 |
Operating Expenses | 252.88 | 212.77 | 189.32 | 138.59 | 124.5 | 110.12 |
Operating Income | -511.09 | -218.67 | -369.79 | 431.6 | 625.69 | 250.06 |
Interest Expense | -129.11 | -148.82 | -77.85 | - | -2.73 | -14.55 |
Interest & Investment Income | 5.12 | 9.98 | 8.87 | 16.4 | 11.75 | 7.73 |
Earnings From Equity Investments | 0.05 | 0.05 | -7.9 | -4.17 | - | - |
Other Non Operating Income (Expenses) | 0.17 | -0.16 | -0.21 | 3.36 | -0.25 | -0.01 |
EBT Excluding Unusual Items | -634.86 | -357.62 | -446.87 | 447.2 | 634.46 | 243.23 |
Gain (Loss) on Sale of Investments | -3.96 | -4.71 | -6.9 | - | - | - |
Asset Writedown | -24.57 | -20.25 | - | 0.06 | - | - |
Other Unusual Items | -23.33 | 2.95 | 1.71 | -4.96 | -2.05 | 2.62 |
Pretax Income | -686.73 | -379.64 | -452.07 | 442.29 | 632.41 | 245.86 |
Income Tax Expense | -11.52 | -10.86 | -0.29 | 63.58 | 93.77 | 31.96 |
Earnings From Continuing Operations | -675.21 | -368.77 | -451.78 | 378.72 | 538.63 | 213.9 |
Minority Interest in Earnings | 181.26 | -11.08 | 39.6 | 7.41 | - | - |
Net Income | -493.94 | -379.85 | -412.18 | 386.12 | 538.63 | 213.9 |
Net Income to Common | -493.94 | -379.85 | -412.18 | 386.12 | 538.63 | 213.9 |
Net Income Growth | - | - | - | -28.32% | 151.82% | 46.36% |
Shares Outstanding (Basic) | 1,276 | 1,276 | 1,056 | 1,053 | 1,053 | 1,053 |
Shares Outstanding (Diluted) | 1,276 | 1,276 | 1,056 | 1,053 | 1,053 | 1,053 |
Shares Change (YoY) | 4.27% | 20.83% | 0.32% | 0.01% | -0.03% | 0.02% |
EPS (Basic) | -0.39 | -0.30 | -0.39 | 0.37 | 0.51 | 0.20 |
EPS (Diluted) | -0.39 | -0.30 | -0.39 | 0.37 | 0.51 | 0.20 |
EPS Growth | - | - | - | -28.32% | 151.90% | 46.33% |
Free Cash Flow | -41.49 | 440.32 | -249.75 | -1,533 | 670.54 | 601.51 |
Free Cash Flow Per Share | -0.03 | 0.34 | -0.24 | -1.46 | 0.64 | 0.57 |
Dividend Per Share | - | - | - | 0.150 | 0.150 | 0.020 |
Dividend Growth | - | - | - | - | 650.00% | - |
Gross Margin | -7.11% | -0.14% | -4.89% | 17.50% | 26.44% | 18.57% |
Operating Margin | -14.08% | -5.29% | -10.02% | 13.25% | 22.05% | 12.89% |
Profit Margin | -13.61% | -9.19% | -11.16% | 11.85% | 18.98% | 11.03% |
Free Cash Flow Margin | -1.14% | 10.66% | -6.76% | -47.05% | 23.63% | 31.01% |
EBITDA | 159.78 | 328.87 | 13.31 | 621.98 | 809.66 | 433.84 |
EBITDA Margin | 4.40% | 7.96% | 0.36% | 19.09% | 28.54% | 22.36% |
D&A For EBITDA | 670.86 | 547.53 | 383.1 | 190.38 | 183.97 | 183.78 |
EBIT | -511.09 | -218.67 | -369.79 | 431.6 | 625.69 | 250.06 |
EBIT Margin | -14.08% | -5.29% | -10.02% | 13.25% | 22.05% | 12.89% |
Effective Tax Rate | - | - | - | 14.37% | 14.83% | 13.00% |
Revenue as Reported | 3,630 | 4,131 | 3,692 | 3,258 | 2,837 | 1,940 |
Advertising Expenses | - | 0.08 | - | - | - | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.